About Symmetry Medical (NYSE:SMA)
Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Industry, Sector and Symbol
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Symmetry Medical (NYSE:SMA) Frequently Asked Questions
What is Symmetry Medical's stock symbol?
Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."
How were Symmetry Medical's earnings last quarter?
Symmetry Medical Inc. (NYSE:SMA) issued its quarterly earnings data on Thursday, October, 30th. The healthcare company reported $0.13 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.15 by $0.02. The healthcare company had revenue of $95.90 million for the quarter, compared to analysts' expectations of $98.24 million. The company's quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.08 EPS. View Symmetry Medical's Earnings History.
Who are some of Symmetry Medical's key competitors?
Some companies that are related to Symmetry Medical include Berkshire Hathaway (BRK.B), Berkshire Hathaway (BRK.A), Alibaba Group (BABA), JPMorgan Chase (JPM), Johnson & Johnson (JNJ), ExxonMobil (XOM), Bank of America (BAC), Royal Dutch Shell (RDS.B), Royal Dutch Shell (RDS.A), Walmart (WMT), Visa (V), Wells Fargo (WFC), Chevron (CVX), UnitedHealth Group (UNH), Taiwan Semiconductor Mfg. (TSM), AT&T (T), Pfizer (PFE) and The Home Depot (HD).
Who are Symmetry Medical's key executives?
Symmetry Medical's management team includes the folowing people:
- Thomas W. Barrett, Senior Vice President and Chief Commercial Officer - OEM Solutions
- Christopher G. Cummins, Senior Vice President, Chief Manufacturing Officer - OEM Solutions (Age 44)
- Stephen Hinora Jr., Senior Vice President - Quality Assurance/Regulatory Affairs (Age 53)
Has Symmetry Medical been receiving favorable news coverage?
Media headlines about SMA stock have been trending somewhat positive on Thursday, according to Accern. The research group rates the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Symmetry Medical earned a media sentiment score of 0.22 on Accern's scale. They also assigned media coverage about the healthcare company an impact score of 45.01 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Symmetry Medical?
Shares of SMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Symmetry Medical?
Symmetry Medical's mailing address is 3724 N STATE ROAD 15, WARSAW, IN 46582, United States. The healthcare company can be reached via phone at +1-574-2682252.
MarketBeat Community Rating for Symmetry Medical (SMA)MarketBeat's community ratings are surveys of what our community members think about Symmetry Medical and other stocks. Vote "Outperform" if you believe SMA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SMA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Symmetry Medical (NYSE:SMA) Analyst Ratings History
(Data available from 4/19/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Symmetry Medical (NYSE:SMA) Earnings History and Estimates Chart
Symmetry Medical (NYSE SMA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/30/2014||Q3||$0.15||$0.13||$98.24 million||$95.90 million||View||Listen|
|8/4/2014||Q2||$0.12||$0.17||$98.38 million||$101.30 million||View||Listen|
|5/1/2014||Q1||$0.09||$0.09||$99.10 million||$101.30 million||View||Listen|
|2/20/2014||Q413||$0.08||$0.10||$101.50 million||$101.20 million||View||Listen|
|10/31/2013||Q313||$0.07||$0.08||$99.05 million||$98.00 million||View||Listen|
|8/1/2013||Q2 2013||$0.08||$0.09||$99.01 million||$101.90 million||View||Listen|
|5/2/2013||Q1 2013||$0.15||$0.06||$106.04 million||$98.90 million||View||Listen|
|2/21/2013||Q4 2012||$0.18||$0.17||$107.81 million||$106.60 million||View||Listen|
|11/1/2012||Q312||$0.15||$0.18||$104.33 million||$100.90 million||View||N/A|
Symmetry Medical (NYSE:SMA) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Symmetry Medical (NYSE SMA) News Headlines
Symmetry Medical (NYSE:SMA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Symmetry Medical (NYSE:SMA) Income Statement, Balance Sheet and Cash Flow Statement
Symmetry Medical (NYSE SMA) Stock Chart for Thursday, April, 19, 2018